Cargando…

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?

BACKGROUND: Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellomo, Giovanni, Cataldi, Samuela, Paciotti, Silvia, Paolini Paoletti, Federico, Chiasserini, Davide, Parnetti, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526419/
https://www.ncbi.nlm.nih.gov/pubmed/32993776
http://dx.doi.org/10.1186/s13195-020-00689-0
_version_ 1783588870006243328
author Bellomo, Giovanni
Cataldi, Samuela
Paciotti, Silvia
Paolini Paoletti, Federico
Chiasserini, Davide
Parnetti, Lucilla
author_facet Bellomo, Giovanni
Cataldi, Samuela
Paciotti, Silvia
Paolini Paoletti, Federico
Chiasserini, Davide
Parnetti, Lucilla
author_sort Bellomo, Giovanni
collection PubMed
description BACKGROUND: Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-analytical variability of these determinations in clinical setting. With respect to classical manual ELISAs, these platforms give us also the possibility to measure any single sample and to get the result within approximately 30 min. So far, reference values have been calculated from measurements obtained in frozen samples. In this work, we wanted to check if the values obtained in fresh CSF samples differ from those obtained in frozen samples, since this issue is mandatory in routine diagnostic work. METHODS: Fifty-eight consecutive CSF samples have been analyzed immediately after lumbar puncture and after 1-month deep freezing (− 80 °C). As an automated platform, we used Lumipulse G600-II (Fujirebio Inc.). Both the fresh and the frozen aliquots were analyzed in their storage tubes. RESULTS: In fresh samples, a mean increase of Aβ40 (6%), Aβ42 (2%), p-tau (2%), and t-tau (4%) was observed as compared to frozen samples, whereas a slight decrease was observed for Aβ42/Aβ40 ratio (4%), due to the higher deviation of Aβ40 in fresh samples compared to Aβ42. These differences are significant for Aβ40, Aβ42/Aβ40 ratio, p-tau, and t-tau. Nevertheless, the Aβ42/Aβ40 ratio showed a lower variability (smaller standard deviation of relative differences) with respect to Aβ42. With respect to the AD profile according to the A/T/(N) criteria for AD diagnosis, no significant changes in classification were observed when comparing results obtained in fresh vs frozen samples. CONCLUSIONS: Small but significant differences have been found for Aβ40, Aβ42/Aβ40 ratio, p-tau, and t-tau in fresh vs frozen samples. Importantly, these differences did not imply a modification in the A/T/(N) classification system. In order to know if different cutoffs for fresh and frozen samples are required, larger, multi-center investigations are needed.
format Online
Article
Text
id pubmed-7526419
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75264192020-10-01 Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ? Bellomo, Giovanni Cataldi, Samuela Paciotti, Silvia Paolini Paoletti, Federico Chiasserini, Davide Parnetti, Lucilla Alzheimers Res Ther Research BACKGROUND: Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-analytical variability of these determinations in clinical setting. With respect to classical manual ELISAs, these platforms give us also the possibility to measure any single sample and to get the result within approximately 30 min. So far, reference values have been calculated from measurements obtained in frozen samples. In this work, we wanted to check if the values obtained in fresh CSF samples differ from those obtained in frozen samples, since this issue is mandatory in routine diagnostic work. METHODS: Fifty-eight consecutive CSF samples have been analyzed immediately after lumbar puncture and after 1-month deep freezing (− 80 °C). As an automated platform, we used Lumipulse G600-II (Fujirebio Inc.). Both the fresh and the frozen aliquots were analyzed in their storage tubes. RESULTS: In fresh samples, a mean increase of Aβ40 (6%), Aβ42 (2%), p-tau (2%), and t-tau (4%) was observed as compared to frozen samples, whereas a slight decrease was observed for Aβ42/Aβ40 ratio (4%), due to the higher deviation of Aβ40 in fresh samples compared to Aβ42. These differences are significant for Aβ40, Aβ42/Aβ40 ratio, p-tau, and t-tau. Nevertheless, the Aβ42/Aβ40 ratio showed a lower variability (smaller standard deviation of relative differences) with respect to Aβ42. With respect to the AD profile according to the A/T/(N) criteria for AD diagnosis, no significant changes in classification were observed when comparing results obtained in fresh vs frozen samples. CONCLUSIONS: Small but significant differences have been found for Aβ40, Aβ42/Aβ40 ratio, p-tau, and t-tau in fresh vs frozen samples. Importantly, these differences did not imply a modification in the A/T/(N) classification system. In order to know if different cutoffs for fresh and frozen samples are required, larger, multi-center investigations are needed. BioMed Central 2020-09-29 /pmc/articles/PMC7526419/ /pubmed/32993776 http://dx.doi.org/10.1186/s13195-020-00689-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bellomo, Giovanni
Cataldi, Samuela
Paciotti, Silvia
Paolini Paoletti, Federico
Chiasserini, Davide
Parnetti, Lucilla
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title_full Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title_fullStr Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title_full_unstemmed Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title_short Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
title_sort measurement of csf core alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526419/
https://www.ncbi.nlm.nih.gov/pubmed/32993776
http://dx.doi.org/10.1186/s13195-020-00689-0
work_keys_str_mv AT bellomogiovanni measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer
AT cataldisamuela measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer
AT paciottisilvia measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer
AT paolinipaolettifederico measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer
AT chiasserinidavide measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer
AT parnettilucilla measurementofcsfcorealzheimerdiseasebiomarkersforroutineclinicaldiagnosisdofreshvsfrozensamplesdiffer